EcoDrugPlus

Ensembl ID : ENSMMMG00000024004
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSMMMG00000001082
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSMMMG00000001509
Gene Symbol: -
Cross references: -
282 Possible Orthologues:

Ensembl ID : ENSMMMG00000005056
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSMMMG00000008815
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Ensembl ID : ENSMMMG00000019776
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSMMMG00000020038
Gene Symbol: -
Cross references: -
61 Possible Orthologues:

Ensembl ID : ENSMMMG00000022420
Gene Symbol: -
Cross references: -
281 Possible Orthologues:

Ensembl ID : ENSMMMG00000022581
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSMMMG00000014975
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSMMMG00000012514
Gene Symbol: -
Cross references: -
171 Possible Orthologues:

Ensembl ID : ENSMMMG00000019194
Gene Symbol: -
Cross references: -
115 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).